Post-approval commitment for SwissMedic-2021-0089. Category: Risk Management. Priority: high.

Commitment ID
COM-089
Authority
Swissmedic
Category
Risk Management
Priority
high
Status
In Progress
Due Date
2025-01-25
Completed At
—
Owner
Dmitri Volkov
Created
2022-07-09
Description

Provide carcinogenicity study report for 2-year rat study

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.